Precision radiation offers new hope for recurrent prostate cancer
NCT ID NCT03312972
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a focused radiation technique called HDR brachytherapy for men whose prostate cancer has come back after earlier radiation treatment. The radiation is placed directly into the cancerous area and removed after a short time, aiming to spare healthy tissue. The trial will enroll 50 participants to check how safe and effective this approach is.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HDR brachytherapy (high-dose-rate radiation implant)
What this could lead to
If successful, this could offer a targeted, less invasive treatment option for men whose prostate cancer has come back after initial radiation therapy.
What could go wrong
This is an early-phase trial with only 50 participants, so results may not apply to everyone. There is a risk of side effects from radiation, and the treatment may not control the cancer long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
University of Virginia School of Medicine
Charlottesville, Virginia, 22908, United States